Nicholas Vollers

London UK

Contact Me Today

Nick is an associate in the Commercialisation team, advising on commercial and regulatory matters within the life sciences and healthcare sector.

Nick has experience working on a range of matters that includes the commercialisation of intellectual property rights, resolving contractual issues, undertaking corporate due diligence and responding to regulatory and compliance questions.

CV

Since 2022 Associate, Taylor Wessing

2018 - 2020 Trainee solicitor, Taylor Wessing

Career

Since 2022 Associate, Taylor Wessing

2018 - 2020 Trainee solicitor, Taylor Wessing

Education

2022 Admitted as a lawyer, England & Wales

2020 LLM Commercial Legal Practice, BPP University London

2019 Graduate Diploma in Law, BPP University London

Experience

Rockpool Investments

Advising Rockpool Investments on its acquisition on orthoses and clinical services provider Talar-Made Ltd.

Press release

Alice Matthews

Nicholas Vollers

Advising on UKAT's acquisition of The Providence Projects

We have advised Sullivan Street Partners and The UKAT Group on UKAT's acquisition of The Providence Projects, one of the country's oldest and most respected rehabilitation centres.

Press release

Nicholas Vollers

Advising on Draig Therapeutics' US$140 million series A financing

We have advised a syndicate of leading global life sciences investors including Access Biotechnology, Canaan Partners and SR One on their landmark US$140 million series A investment in Draig Therapeutics.

Press release

Ross McNaughton

Elinor Picton

Oli Denne

Helen Farr

Adrian Toutoungi

Charlie Adams

Nicholas Vollers

Ed Chapman

Advising Hims & Hers Health, Inc

Our team has advised Hims & Hers Health, Inc. (NYSE: HIMS), a leading US digital health and wellness company based in San Francisco, on its agreement to acquire ZAVA Global GmbH, one of the market-leading digital health platforms and telemedicine providers in Europe.

Press release

Nicholas Vollers

Advising Sullivan Street Partners on its acquisition of UK Addiction Treatment Group

We have advised Sullivan Street Partners, a UK-based mid-market buy-out specialist, on its acquisition of UK Addiction Treatment Group (UKAT), the UK’s leading, residential addiction treatment group.

Press release

Kayla Sinclair

Nicholas Vollers

Advising Cumulus Oncology on its exclusive GPR68 licence and development collaboration

Advising Cumulus Oncology on its collaboration agreement with leadXpro to develop small molecules against GPR68, an important proton sensing G protein coupled receptor.

Press release

Nicholas Vollers

Charlie Adams